Production and characterization of monoclonal antibody that simultaneously recognizes methamphetamine ant its major metabolite

Cited 5 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorKyung Soo Nam-
dc.contributor.authorJae Wha Kim-
dc.contributor.authorMyung Ja Choi-
dc.contributor.authorMi Young Han-
dc.contributor.authorIn Seong Choe-
dc.contributor.authorTai Wha Chung-
dc.date.accessioned2017-04-19T08:55:15Z-
dc.date.available2017-04-19T08:55:15Z-
dc.date.issued1993-
dc.identifier.issn0918-6158-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/4349-
dc.description.abstractA series of monoclonal antibodies (mAbs) that react with methamphetamine-bovine serum albumin (MA-BSA) were established by intrasplenic immunization method. Among established 36 clones, two typical mAbs, designated NK-l and NK-2, were described. The inhibition assay of enzyme-linked immunosorbent assay (ELISA) analysis using methamphetamine analogs indicated that NK-1 showed considerable reactivity not only MA-BSA but also methamphetamine and its major metabolite, para-hydroxymethamphetamine (p-hydroxymethamphetamine). The cross-reactivity between NK-1 and the methamphetamine analogs with modified alkyl side chain, indicates that methyl groups of R5 and R7 in the methamphetamine molecules are important for the maximum affinity. The length of alkyl side chain on methamphetamine significantly affected the binding affinity of NK-1. The results may suggest that NK-1 will recognize not only methamphetamine but also the bridge part of the methamphetamine that binds the methamphetamine molecules to a carrier protein.-
dc.publisherPharmaceutical Soc Japan-
dc.titleProduction and characterization of monoclonal antibody that simultaneously recognizes methamphetamine ant its major metabolite-
dc.title.alternativeProduction and characterization of monoclonal antibody that simultaneously recognizes methamphetamine ant its major metabolite-
dc.typeArticle-
dc.citation.titleBiological & Pharmaceutical Bulletin-
dc.citation.number5-
dc.citation.endPage492-
dc.citation.startPage490-
dc.citation.volume16-
dc.contributor.affiliatedAuthorJae Wha Kim-
dc.contributor.affiliatedAuthorMi Young Han-
dc.contributor.affiliatedAuthorIn Seong Choe-
dc.contributor.affiliatedAuthorTai Wha Chung-
dc.contributor.alternativeName남경수-
dc.contributor.alternativeName김재화-
dc.contributor.alternativeName최명자-
dc.contributor.alternativeName한미영-
dc.contributor.alternativeName최인성-
dc.contributor.alternativeName정태화-
dc.identifier.bibliographicCitationBiological & Pharmaceutical Bulletin, vol. 16, no. 5, pp. 490-492-
dc.identifier.doi10.1248/bpb.16.490-
dc.subject.keywordmonoclonal antibody-
dc.subject.keywordmethamphetamine-
dc.subject.keywordp-hydroxymethamphetamine-
dc.subject.localmonoclonal antibodies-
dc.subject.localmonoclonal antibody-
dc.subject.localMonoclonal Antibodies-
dc.subject.localMonoclonal Antibody-
dc.subject.localMonoclonal antibodies-
dc.subject.localMonoclonal antibody-
dc.subject.localMonoclonal antibody (mAb)-
dc.subject.localmethamphetamine-
dc.subject.localMethamphetamine-
dc.subject.localp-hydroxymethamphetamine-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Immunotherapy Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.